Global health

Sapient Receives $9.2M Grant for Population-Scale Discovery Mass Spectrometry Analysis

Retrieved on: 
Monday, July 11, 2022
Science, Other Science, Biometrics, Biotechnology, Research, Pharmaceutical, Health, Health Technology, Health, Lists of countries and territories, Melinda Gates, Infection, Human, COVID-19, CEO, Disease, Metabolomics, Bill, Doctor of Philosophy, Hypoxia, Biomarker, Global health, Woman, Bill & Melinda Gates Foundation, Research, Scale of Protective Factors, MD, Mass spectrometry, Child, Pharmaceutical industry, Sapient

Sapients untargeted, high throughput discovery metabolomics platform will be applied to analyze tens of thousands of biosamples collected through programs conducted by Bill & Melinda Gates Foundation grantees in its Global Health Discovery Collaboratory .

Key Points: 
  • Sapients untargeted, high throughput discovery metabolomics platform will be applied to analyze tens of thousands of biosamples collected through programs conducted by Bill & Melinda Gates Foundation grantees in its Global Health Discovery Collaboratory .
  • In addition to rLC-MS analysis, the new grant will enable Sapient to provide grantees with support for biocomputational analyses and molecule identification of key discovered biomarkers, as well as capacity building for analytical and data handling capabilities among the grantees.
  • This grant allows us to perform population-level analyses for a highly unique scale of discovery that amplifies our ability to identify robust, specific small molecule biomarkers of health and disease.
  • Sapient is an end-to-end biomarker discovery organization dedicated to accelerating the mapping of circulating chemistries in humans through rapid, large-scale small molecule biomarker profiling.

Harmony Health Selected for Amazon Web Services (AWS) Health Equity Initiative

Retrieved on: 
Monday, July 11, 2022
Cloud, Health, Solution, AWS, CEO, Program, Amazon Web Services, Harmony, Communication, Community, Global health, Intelligence, Silicon, Organization, Andrew Kohut, Health equity, Medicine, Health insurance, Mobile phone

PLEASANTON, Calif., July 11, 2022 /PRNewswire-PRWeb/ -- Harmony Health today announced that it has been selected for Amazon Web Services's (AWS's) Health Equity Initiative, supporting organizations that are developing solutions to advance health equity.

Key Points: 
  • Harmony Health will receive computing credits and technical expertise from Amazon Web Services to connect diverse communities to health equity services through their trusted Community-based Organizations.
  • PLEASANTON, Calif., July 11, 2022 /PRNewswire-PRWeb/ -- Harmony Health today announced that it has been selected for Amazon Web Services's (AWS's) Health Equity Initiative , supporting organizations that are developing solutions to advance health equity.
  • The Harmony Health micro-engagement enables:
    "Harmony Health micro-engagement platform helps amplify the inclusive initiatives and efforts of trusted messengers, and allows them to connect with individuals at scale and in real-time context," said Vineet Gulati , CEO of Harmony Health.
  • Through our Health Equity Initiative, we look forward to helping Harmony Health and other organizations worldwide use AWS to advance health equity and improve health outcomes."

After Record Setting Launch of Beyond Raw® Concept X, GNC Continues Innovation with New JOLLY RANCHER Grape

Retrieved on: 
Friday, July 8, 2022
Well, Myalgia, Solution, View, Partnership, Global health, Multimedia, Industry, The Hershey Company, GNC, Jolly Rancher

PITTSBURGH, July 8, 2022 /PRNewswire/ -- Beyond Raw® is back with a limited time pre-workout exclusively at GNC: JOLLY RANCHER Grape. With a loyal consumer base ravenous for new flavors to mix into their workout routines, GNC is delivering with Beyond Raw® LIT™ JOLLY RANCHER Grape which joins the ranks of fan-favorites Watermelon, Green Apple, and Blue Raspberry. Known to help athletes dominate in the gym like no other, Beyond Raw® LIT's™ ingredients have been scientifically proven to promote energy, focus, and increase muscle carnosine levels on both training and non-training days. And now, fitness fanatics can experience the Beyond Raw® way in another coveted, mouth-watering JOLLY RANCHER flavor.

Key Points: 
  • "Our continued partnership with GNC allows us to create a new path for consumers to experience the mouthwatering Jolly Rancher flavors and are thrilled to add grape to the lineup."
  • The Beyond Raw LITJOLLY RANCHER Grape follows the launch of Beyond Raw Concept X in May, a first-of-its-kind supplement transforming the industry and redefining what consumers can expect from a pre-workout including extreme energy, focus, pumps, strength, endurance, and muscle soreness support.
  • Now, more than ever, Beyond Raw is helping consumers Live Well without sacrificing taste, fun, or results.
  • By combining exceptional innovation, product development capabilities and an extensive global distribution network, GNC manages a best-in-class product portfolio.

Elbit Systems Launches Innovative Helicopter Vision Suite that Enables Pilots to "Own the Weather"

Retrieved on: 
Friday, July 8, 2022
Global health, Aircraft, LinkedIn, Securities Act of 1933, Securities Exchange Act of 1934, Nose, Weather, Estoppel, Form 20-F, Mark (given name), Elbit Systems, Intelligence, Company, U.S. Securities and Exchange Commission, EW, Intellectual property, Annual report, Augmented reality, Compliance, Infrared, HMD, Technology, Maritime Transportation Security Act of 2002, Private Securities Litigation Reform Act, Radar, Environment, Software, Aircraft pilot, Machine learning, Facebook, Artificial intelligence, Computer, AI, Patent, Twitter, Program, Forward-looking statement, Satellite navigation device, Instrumentation, Risk management, Xplore

HAIFA, Israel, July 8, 2022 /PRNewswire/ -- Elbit Systems unveils an innovative technological vision suite for military helicopters (a fifth generation aircraft technology). The new suite integrates a sophisticated sensor array, an Artificial Intelligence (AI) powered mission computer and a unique Helmet Mounted Display (HMD) system. The new suite enables helicopter pilots to see through the body of the aircraft and provides them with a real-time, clear, colored wide field of view, during day and night, in challenging weather and visibility condition. These capabilities address one of the toughest operational challenges of military helicopters – conducting low-altitude flights during degraded visibility conditions, significantly expanding the operational envelop of military helicopters, transforming extreme weather and other degraded visibility conditions into an operational advantage.

Key Points: 
  • HAIFA, Israel, July 8, 2022 /PRNewswire/ -- Elbit Systems unveils an innovative technological vision suite for military helicopters (a fifth generation aircraft technology).
  • The innovative Xplore is a compact sophisticated airborne radar that can be installed onboard any aircraft enabling flight during all visibility conditions.
  • Elbit Systems Ltd., its logo, brand, product, service and process names appearing in this Press Release are the trademarks or service marks of Elbit Systems Ltd. or its affiliated companies.
  • Reference to or use of a product, service or process other than those of Elbit Systems Ltd. does not imply recommendation, approval, affiliation or sponsorship of that product, service or process by Elbit Systems Ltd.

Health Affairs' Journal Impact Factor Rises To 9.048 And Rank Is No. 1

Retrieved on: 
Wednesday, July 6, 2022
Global health, Affair, JCR, Research, Health Affairs, Health, COVID-19, Policy, No, Health policy, Leadership, HOPE, News, Medical device, Pharmaceutical industry, Clarivate

WASHINGTON, July 06, 2022  /PRNewswire-PRWeb/ -- Health Affairs' continued leadership in the field of health policy is validated by its highest-ever Journal Impact Factor of 9.048, according to the recently released Journal Citation Reports® (JCR) 2022 from Clarivate. This is a 44 percent increase from Health Affairs' 2021 Journal Impact Factor. The journal also earned the No. 1 ranking in the Health Policy And Services category, ahead of 87 other journals in the field.

Key Points: 
  • WASHINGTON, July 06, 2022 /PRNewswire-PRWeb/ -- Health Affairs' continued leadership in the field of health policy is validated by its highest-ever Journal Impact Factor of 9.048, according to the recently released Journal Citation Reports (JCR) 2022 from Clarivate.
  • This is a 44 percent increase from Health Affairs' 2021 Journal Impact Factor.
  • Health Affairs is the leading peer-reviewed https://www.healthaffairs.org/ journal at the intersection of health, health care, and policy.
  • Join Health Affairs editors on Health Affairs This Week as they discuss the week's most pressing health policy news.

Microsoft Canada Recognizes Smile CDR as Winner of the 2022 ISV Breakthrough Partner Impact Award

Retrieved on: 
Wednesday, July 6, 2022
GLOBE, Global health, Ecosystem, Organization, HL7, Patient, Microsoft, ISV, Canada, Video game

Our collaboration with Microsoft has amplified our efforts toward better global health, enhancing and simplifying the digital experience for users of the services we offer," said Duncan Weatherston, Chief Executive Officer, Smile CDR.

Key Points: 
  • Our collaboration with Microsoft has amplified our efforts toward better global health, enhancing and simplifying the digital experience for users of the services we offer," said Duncan Weatherston, Chief Executive Officer, Smile CDR.
  • Microsoft Canada presented these awards in 32 categories on July 5, 2022, as part of a lead-up to Microsoft's Inspire conference.
  • "We are pleased to recognize Smile CDR as this year's recipient of the ISV Breakthrough Partner Impact Award," said Suzanne Gagliese, Vice President, Global Partner Solutions, Microsoft Canada.
  • Smile CDR Inc. is a health information technology company focused on delivering better global health through open standards.

Global Health and Fitness Club Industry Report 2022 - Insights Into Membership Fees, Total Admission Fees, Personal Training & Instruction Services - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 6, 2022
Fitness & Nutrition, Health, Wharf (Holdings) Ltd. v. United International Holdings, Inc., Planet Fitness, Global health, Health, Marketing, COVID-19, Exercise, Advertising, Industry, Obesity, Ageing, Awareness, CAGR, UFC, Environment, Degenerative disease, Rimini Street Inc. v. Oracle USA Inc., Gen, Crunch Fitness, Diabetes, Nightclub, Growth

The "Health and Fitness Club Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Health and Fitness Club Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The global health and fitness club market is projected to witness a CAGR of 7.21% during the forecast period 2022-2027.
  • Attractive membership fees offered by fitness clubs and increasing spending on marketing and advertisement are helping health and fitness clubs generate more revenue.
  • The major strategies adopted by companies operating in the global health and fitness club market are expansions and mergers and acquisitions.

Pixelworks Powers ROG Phone 6 Series to New Benchmark for Mobile Gaming Experience

Retrieved on: 
Tuesday, July 5, 2022
Shift, Qualcomm, PXLW, ROG, Annual report, Color, Artifact, Global health, Securities Act of 1933, Securities Exchange Act of 1934, Antirrhinum, Electronics, Netflix, HDR, SOC, Small Business Saturday, AMOLED, Company, Republic, Smartphone, U.S. Securities and Exchange Commission, Certification, YouTube, Energy Independence and Security Act of 2007, Technology, Leia (company), Software, General manager, SEC, Module (mathematics), NASDAQ, Amazon, Asus, ASUS, PWM, Eye, GM, Multimedia, Video game, Mobile phone, Camera, Television, Security (finance), COVID-19, Pixelworks, Tencent

SHANGHAI, July 5, 2022 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions today announced the recently launched ASUS ROG Phone 6 series integrates the Company's visual processing solutions, including industry-leading HDR technology, professional color calibration, DC Dimming and other advanced features. In addition to providing an authentic visual experience with great eye-comfort for all ASUS users, the ROG Phone 6 model sold in China will be offered in collaboration with Tencent Games, a division of Tencent, producing uniquely vibrant colors with greater contrast and even more visual details for Tencent gaming contents.

Key Points: 
  • The combination of excellent performance and high refresh rate display establishes a new benchmark for the ultimate mobile gaming experience.
  • To further elevate users' visual experience while mobile gaming, Pixelworks also provides Color Enrich mode to optimize both gaming and HDR 10+ video content on the ROG Phone 6 series.
  • "We are pleased to continue our cooperation with Pixelworks on ROG Phone 6 series smartphones," commented Bryan Chang, General Manager, Smartphone Business Unit at ASUS.
  • We believe that the ROG Phone 6 series will prove to justify the long wait of ROG fans with its captivating gaming performance."

SAB Biotherapeutics Hosts U.S. Representatives Dusty Johnson and Dean Phillips for South Dakota Facility Tour

Retrieved on: 
Tuesday, July 5, 2022
Global health, LinkedIn, Patient, Plasma, Pleasure, Probability, Genetic engineering, Phillips, TC, GLOBE, COVID-19, Cancer, U.S. Securities and Exchange Commission, SAB, Forward-looking statement, Infection, Organ transplantation, Degenerative disease, Therapy, Antibody, Member of Congress, Nasdaq, Private Securities Litigation Reform Act, Time, Immunotherapy, Government, Twitter, Security (finance), Vaccine, Pharmaceutical industry

Congressmen Dusty Johnson (R-SD) and Dean Phillips (D-MN-3) on Friday, July 1, for a tour of SABs facilities and to learn about SABs innovative immunotherapy platform that enables a scalable and reliable production of polyclonal antibodies.

Key Points: 
  • Congressmen Dusty Johnson (R-SD) and Dean Phillips (D-MN-3) on Friday, July 1, for a tour of SABs facilities and to learn about SABs innovative immunotherapy platform that enables a scalable and reliable production of polyclonal antibodies.
  • During their visit, Congressmen Johnson and Phillips toured SABs Plasma Production Facility, featuring the companys transchromosomic (Tc) Bovinegenetically engineered cattlewhich provide SABs fully human polyclonal antibodies for therapeutics.
  • We were pleased to host Congressmen Johnson and Phillips at SAB.
  • Actual events and circumstances are difficult or impossible to predict, will differ from assumption and are beyond the control of SAB.

Adagio Announces David Hering Named Permanent Chief Executive Officer and Director

Retrieved on: 
Tuesday, July 5, 2022
Death, Annual report, Patient, Global health, CEO, Research, Hospital, GLOBE, Infection, COVID-19, Growth, Industry, Disease, U.S. Securities and Exchange Commission, Forward-looking statement, Technology, Private Securities Litigation Reform Act, Organization, Nasdaq, SEC, Board, Leadership, Safety, Immunity, Severe acute respiratory syndrome coronavirus 2, Therapy, Security (finance), Pfizer, Pharmaceutical industry, Vaccine, Adagio

WALTHAM, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc. (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases, announced today that industry and infectious disease veteran David Hering, who has been serving as the companys interim chief executive officer and chief operating officer, has been named permanent CEO and a director on the companys Board of Directors.

Key Points: 
  • WALTHAM, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc. (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases, announced today that industry and infectious disease veteran David Hering, who has been serving as the companys interim chief executive officer and chief operating officer, has been named permanent CEO and a director on the companys Board of Directors.
  • He is the ideal person to lead Adagio through its next phase of growth, and we are thrilled to appoint him as CEO and director.
  • We believe Adagio has best-in-class antibody discovery and development capabilities and to fully realize its potential the company requires leadership with substantial operational and commercial experience.
  • We are excited about the road ahead for Adagio and the impact we may have on people in need.